by Alex McGuire
Natural Gas News: Natural gas prices today (Thursday) abruptly declined after the U.S. Energy Information Administration (EIA) released its weekly supply report.
But with global demand on the rise, prices will follow.
Here's what you need to know about natural gas prices today - and how you can profit...
An ancient economic pattern is about to repeat itself – one that can make you money.
Wall Street denies that there is profitability potential here. So why are the investing elite piling in?
by Diane Alter
Cheniere Energy Inc. (NYSEMKT: LNG) stock climbed 3.4% yesterday (Wednesday) when U.S. President Barack Obama vetoed Keystone XL pipeline legislation.
LNG stock has been one of our favorite energy picks for more than four years. Money Morning Global Energy Strategist Dr. Kent Moors first alerted readers to its profit potential in November 2011 – when it was trading at $10.37 a share.
And it's not too late to profit. Here's why LNG stock will continue to climb...
Global healthcare mergers and acquisitions (M&As) have soared 124% so far this year, to $35.1 billion. Of course, Wall Street doesn't want you to know that.
In fact, they declared the industry dead. But we know better.
Here's how to pounce on the ongoing biopharma M&A trend while every other investor gets bluffed...
by Greg Madison
Google Inc.'s (Nasdaq: GOOG) plan to merge its European operations might look like a defensive pullback, but it's really a potential buying opportunity. In fact, Money Morning's Defense and Tech Specialist Michael Robinson thinks the stock could soar 50% over the next three and a half years.
The search giant said on February 25 that it would merge its two European divisions.
by David Zeiler
We're in the very first stages of a leap in wearable tech that will rival the greatest breakthroughs in how we use computers.
It's called augmented reality. It's a type of holographic projection, but merged with the real world.
And the company at the cutting edge of this revolutionary wearable technology isn't Google, Apple, or Sony.
It's Microsoft Corp. (Nasdaq: MSFT).
Good Morning! Futures for Thursday, Feb. 26, forecast a 14-point gain for the DJIA today from yesterday's close.
What to Watch Today: This morning, investors will turn an eye to domestic data. News broke this morning that 313,000 Americans filed for unemployment benefits last week. The data was higher than consensus expectations of 290,000 filings. In addition, investors will watch for January readings on the Consumer Price Index and Durable Goods Orders.
by Tom Gentile
[Editor's Note: Tom Gentile is the co-founder of Optionetics, a financial education company which he later sold to one of the world's largest retail brokerages. Tom leveraged his 25 years of experience trading stocks, futures, and options to teach more than 300,000 people the secrets to profitable, low-risk investing.
Tom is the author of a book, The Trading Index Course, which lays out the basis of his highly successful system for trading options, and he's a frequent contributor to CNBC, Reuters, Bloomberg, and FOX. We're excited to have him with us…]
Oil has been a glutton for punishment, getting rocked by sellers and dropping some 55% from the highs of last July.
Up until just a few months ago, nearly every analyst and hedge fund manager in this space was offering up his or her commentary on how oil had bottomed and how it was time to buy.
Now it seems that fewer traders are willing to make that call, offering a glimmer of hope for contrarians like myself.
The Dow Jones Industrial Average today eked out a 15-point gain to close at yet another record high, while the Nasdaq and S&P 500 retreated marginally.
Two things made for a choppy trading session today. First, Federal Reserve Chair Janet Yellen gave no new information on when the central bank will raise rates. Second, data on new home sales were mixed.
Here are all the top stories from today, plus our new profit tip for investors...
A sector of the pharmaceutical market known as "high-margin specialty drugs" is presenting us with the best pharmaceutical stocks to buy now.
According to experts at PricewaterhouseCoopers, consumer spending on high-margin specialty drugs hit $87.1 billion in 2012. In five years that number will quadruple to $401.7 billion.
The Wall Street Journal reports that total U.S. prescription drug spending was just $325.7 billion in 2012.
And those aren't the only alarming growth numbers boosting pharma stocks now...
